Jugular venous and arterial concentrations of serum S100B protein in patients with severe head injury;Concentrations sériques jugulaire et artérielle de la protéine S100B chez les patients victimes d'un traumatisme crânien grave

Annales de Biologie Clinique

Volumn 70, Issue 3, 2012, Pages 269-275

  Bouvier, Damien ^a   Eisenmann, Nathanaël ^b   Gillart, Thierry ^b   Bonneau, Juliette ^b   Guelon, Dominique ^b   Schoeffler, Pierre ^b   Sapin, Vincent ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b Service de réanimation médico chirurgicale HÔpital Gabriel Montpied   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Jugular venous concentration; S100B protein; Severe head injury

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ADOLESCENT; ADULT; AGED; ARTERY; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION; FEMALE; GLASGOW COMA SCALE; HEAD INJURY; HOSPITALIZATION; HUMAN; JUGULAR VEIN; MALE; MIDDLE AGED; OSMOLARITY; PROGNOSIS; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIES; CASE-CONTROL STUDIES; CRANIOCEREBRAL TRAUMA; FEMALE; GLASGOW COMA SCALE; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; OSMOLAR CONCENTRATION; PROGNOSIS; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84861081318     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2012.0701     Document Type: Article

References (29)

1. Tiret L, Hausherr E, Thicoïpé M, Garros B, Maurette P, Castel JP, etal. The epidemiology of head Trauma in Aquitaine (France), 1986 : a community based study of hospital admissions and deaths. Int J Epidemiol 1990; 19 :133-40. (Pubitemid 20126847)
2. Masson F, Thicoipe M, Mokni T, Aye P, Erny P, Dabadie P. Aquitaine Group for Severe Brain Injury Study. Epidemiology of traumatic comas : a prospective population-based study. Brain Inj 2003 ; 17 : 279-93. (Pubitemid 36422685)
3. Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A sys-tematic review of brain injury epidemiology in Europe. Acta Neurochir 2006 ; 148 : 255-68.
4. CRASH Trial Collaborators. Predicting outcome after traumatic brain injury : practical prognostic models based on large cohort of international patient. BMJ 2008 ; 336 : 425-9.
5. Davis DP, Serrano JA, Vilke GM, Sise MJ, Kennedy F, Eastman AB, et al. The predictive value of field versus arrival Glasgow coma score and TRISS calculations in moderate to severe traumatic brain injury. J Trauma 2006 ; 60 : 985-90. (Pubitemid 43778629)
6. Myburgh J, Cooper DJ, Finfer SR, Venkatesh B, Jones D, Higgins A, et al. Epidemiology and 12-months outcomes from traumatic brain injury in Australia and New Zealand. J Trauma 2008 ; 64 : 854-62. (Pubitemid 351521868)
7. Rouxel JMP, Tazarourte K, Le Moigno S, Ract C, Vigué B. Prise en charge préhospitalière des traumatisés crâniens. Ann Fr Anesth Réanim 2004 ; 23 : 6-14. (Pubitemid 38251240)
8. The Brain Trauma Fondation. Guidelines for the management of trau-matic brain injury. J Neurotrauma 2007 ; 24 : 1-106.
9. Fakhry SM, Trask AL, Waller MA, Watts DD. Management of brain injury patients by an evidence based medicine protocol improves outcomes and decreases hospital charges. J Trauma 2004 ; 56 : 492-500. (Pubitemid 38523697)
10. Bulger EM, Nathens AB, Rivara FP, Moore M, Mac Kenzie EJ, Jurkovich GJ. Management of severe head injury : institutional variations in care and effects on outcome. Crit Care Med 2002 ; 30 : 1870-6. (Pubitemid 34879606)
11. Faul M, Wald MM, Rutland-Brown W, Sullivent EE, Sattin RW. Using a cost-benefic analysis to estimate outcomes of clinical treatment guide-lines : testing the brain trauma fondation guidelines for the treatment of severe traumatic brain injury. J Trauma 2007 ; 63 : 1271-8.
12. Beaudeux JL, Dequen L, Foglietti MJ. La protéine S-100beta: un nou-veau marqueur biologique de pathologie cérébrale. Ann Biol Clin 1999 ; 57 : 261-72.
13. Beaudeux JL, Soler C, Foglietti MJ. Physiopathologie de la protéine S-100B : intérêt de son dosage en biologie clinique. Immunoanal Bio Spec 2002; 17 : 280-6. (Pubitemid 38199686)
14. Beaudeux JL, Roche S, Puyssabet L, Foglietti MJ. Physiologie de la protéine S100B et apport de son dosage dans les pathologies neurolo-giques. Immunoanal Biol Spec 2001 ; 16 : 14-148.
15. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. J Neurosurg 1999 ; 13 : 56-9. (Pubitemid 29139950)
16. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999 ; 45 : 477-83. (Pubitemid 29428663)
17. Raabe A, Grolms C, Keller M. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir 1998 ; 140 : 787-92. (Pubitemid 28419961)
18. Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, etal. Protein S-100b serum levels in traumainduced brain death. Neurology 2003; 60 : 947-51. (Pubitemid 36348926)
19. Woertgen C, Rothoerl R, Holzschuh M, Metz C, Brawanski A. Com-parison of serial S100 and NSE serum measurements after severe head injury. Acta Neurochir (Wein) 1997 ; 139 : 1161-4.
20. Rothoerl R, Woertgen C, Brawanski A. S-100 serum levels and outcome after severe head injury. Acta Neurochir Suppl 2000 ; 76 : 97-100.
21. Woertgen C, Rothoerl R, Metz C, Brawanski A. A comparison of clinical, radiologic and serum marker of prognostic factors after severe head injury. J Trauma 1999 ; 47 : 1126-30. (Pubitemid 30007572)
22. Pleines U, Morganti-Kossmann M, Rancan M, Joller H, Trentz O, Kossmann T. S100Breflects the injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001 ; 18 : 491-8. (Pubitemid 32472839)
23. Korfias S, Stranjalis G, Boviatsis E, Psachoulia C, Jullien G, Gregson B, et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 2007 ; 33 : 225-60.
24. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker : Results using a single (24 h) time-point. Resuscitation 2009 ; 80 : 341-5.
25. Murillo-Cabezas F, Munoz-Sanchez MA, Rincon-Ferrari MD, Martin-Rodriguez JF, Amaya-Villar R, Garcia-Gomez S, et al. The pro-nostic value of the temporal course of S100ß protein in post-acute severe brain injury : a prospective and observationnal study. Brain Injury 2010 ; 24 : 609-19.
26. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury : a pilot study. J Neurol Neurosurg Psychiatry 1998 ; 65 : 930-2. (Pubitemid 128710439)
27. Mc Keating E, Andrews P, Mascia L. Relationship of neuron specific enolase and S100 concentrations in systemic andjugular venous serumto injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl(Wein) 1998 ; 71 : 117-9. (Pubitemid 128444374)
28. Anderson RE, Hansson LO, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 2001 ; 71 : 1512-7.
29. Jönsson H, Johnsson P, Höglund P, Alling C, Blomquist S. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000 ; 14 : 698-701.